Coronavirus enzyme inhibitors-experimentally proven natural compounds from plants

J Microbiol. 2022 Mar;60(3):347-354. doi: 10.1007/s12275-022-1499-z. Epub 2022 Jan 28.

Abstract

Coronavirus disease (COVID-19) can cause critical conditions that require efficient therapeutics. Several medicines are derived from plants, and researchers are seeking natural compounds to ameliorate the symptoms of COVID-19. Viral enzymes are popular targets of antiviral medicines; the genome of coronaviruses encodes several enzymes, including RNA-dependent RNA polymerase and viral proteases. Various screening systems have been developed to identify potential inhibitors. In this review, we describe the natural compounds that have been shown to exert inhibitory effects on coronavirus enzymes. Although computer-aided molecular structural studies have predicted several antiviral compound candidates, the current review focuses on experimentally proven natural compounds.

Keywords: COVID-19; SARS-CoV-2; coronavirus; natural compounds.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / pharmacology*
  • COVID-19 Drug Treatment*
  • Enzyme Inhibitors* / pharmacology
  • Humans
  • Phytochemicals / pharmacology*
  • RNA-Dependent RNA Polymerase / antagonists & inhibitors
  • SARS-CoV-2 / drug effects
  • SARS-CoV-2 / enzymology

Substances

  • Antiviral Agents
  • Enzyme Inhibitors
  • Phytochemicals
  • RNA-Dependent RNA Polymerase